Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VIDAZA® Drug Use Examination

NCT02137629 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02137629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02137629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VIDAZA® Drug Use Examination
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
December 27, 2010
Completion date
May 19, 2016
Enrollment
511 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome